S100A6: A Potential Drug Target and Biomarker (G6277)

Target Name: S100A6

NCBI ID: G6277

S100A6

S100A6: A Potential Drug Target and Biomarker

S100A6 is a protein that is expressed in various tissues and cell types in the human body. Its function is not well understood, but it is known to play a role in the regulation of cell proliferation, differentiation, and survival. S100A6 has also been implicated in the development and progression of various diseases, including cancer. As a result, S100A6 has emerged as a potential drug target and biomarker for a variety of diseases.

S100A6 is a member of the S100 family of proteins, which includes several other proteins that are involved in the regulation of cell proliferation and differentiation. The S100 family of proteins are characterized by the presence of a unique domain called the N-terminal hypervariable region (HVR), which is responsible for the diversity of their amino acid sequences.

S100A6 is expressed in a variety of tissues and cells, including muscle, nerve, heart, and cancer cells. It is also expressed in the placenta, which is the site of fetal development and growth. S100A6 has been shown to be involved in the regulation of cell proliferation and differentiation, as well as in the development and progression of various diseases.

One of the most promising aspects of S100A6 is its potential as a drug target. S100A6 has been shown to play a role in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. This is important for the development and maintenance of tissues and organs, and is also involved in the development of cancer.

S100A6 has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

In addition to its potential as a drug target, S100A6 has also been shown to be a potential biomarker for a variety of diseases. Its expression has been shown to be associated with the development and progression of various diseases, including cancer. This suggests that S100A6 may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, S100A6 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its function and its potential as a therapeutic agent.

Protein Name: S100 Calcium Binding Protein A6

Functions: May function as calcium sensor and modulator, contributing to cellular calcium signaling. May function by interacting with other proteins, such as TPR-containing proteins, and indirectly play a role in many physiological processes such as the reorganization of the actin cytoskeleton and in cell motility. Binds 2 calcium ions. Calcium binding is cooperative

The "S100A6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about S100A6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets